JPWO2021113642A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021113642A5 JPWO2021113642A5 JP2022534352A JP2022534352A JPWO2021113642A5 JP WO2021113642 A5 JPWO2021113642 A5 JP WO2021113642A5 JP 2022534352 A JP2022534352 A JP 2022534352A JP 2022534352 A JP2022534352 A JP 2022534352A JP WO2021113642 A5 JPWO2021113642 A5 JP WO2021113642A5
- Authority
- JP
- Japan
- Prior art keywords
- vector
- protein
- acid sequence
- promoter
- active fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025104155A JP2025126223A (ja) | 2019-12-05 | 2025-06-19 | 変形性関節症の治療方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962944027P | 2019-12-05 | 2019-12-05 | |
| US62/944,027 | 2019-12-05 | ||
| PCT/US2020/063319 WO2021113642A1 (en) | 2019-12-05 | 2020-12-04 | Methods for treating osteoarthritis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025104155A Division JP2025126223A (ja) | 2019-12-05 | 2025-06-19 | 変形性関節症の治療方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023504201A JP2023504201A (ja) | 2023-02-01 |
| JP2023504201A5 JP2023504201A5 (https=) | 2023-12-11 |
| JPWO2021113642A5 true JPWO2021113642A5 (https=) | 2023-12-11 |
| JP7701359B2 JP7701359B2 (ja) | 2025-07-01 |
Family
ID=76222269
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022534352A Active JP7701359B2 (ja) | 2019-12-05 | 2020-12-04 | 変形性関節症の治療方法 |
| JP2025104155A Pending JP2025126223A (ja) | 2019-12-05 | 2025-06-19 | 変形性関節症の治療方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025104155A Pending JP2025126223A (ja) | 2019-12-05 | 2025-06-19 | 変形性関節症の治療方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230024183A1 (https=) |
| EP (1) | EP4069313A4 (https=) |
| JP (2) | JP7701359B2 (https=) |
| KR (1) | KR20220119056A (https=) |
| CN (1) | CN115515645A (https=) |
| AU (1) | AU2020398637A1 (https=) |
| CA (1) | CA3160033A1 (https=) |
| WO (1) | WO2021113642A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250000512A (ko) | 2023-06-27 | 2025-01-03 | 동신대학교산학협력단 | 요오드아세트산 나트륨 유도 골관절염에 양릉천과 현종 혈위를 자극하는 침습형 레이저침을 이용한 치료 방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3548999A (en) * | 1998-04-03 | 1999-10-25 | Chiron Corporation | Use of igfi for treating articular cartilage disorders |
| CA2330939A1 (en) * | 1998-06-16 | 1999-12-23 | Biogen, Inc. | Variant type ii tgf-beta receptor fusion proteins and methods |
| TW200936156A (en) * | 2008-01-28 | 2009-09-01 | Novartis Ag | Methods and compositions using Klotho-FGF fusion polypeptides |
| NZ590667A (en) * | 2008-07-02 | 2013-01-25 | Emergent Product Dev Seattle | Tgf-b antagonist multi-target binding proteins |
| JP7632835B2 (ja) * | 2016-05-20 | 2025-02-19 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 加齢関連疾患及び症状の遺伝子治療法 |
| WO2017210607A1 (en) * | 2016-06-02 | 2017-12-07 | Klotho Therapeutics, Inc. | Therapeutic recombinant klotho proteins and compositions and methods involving the same |
| EP3551212A4 (en) * | 2016-11-22 | 2020-11-04 | Klotho Therapeutics, Inc. | NEW RECOMBINATED KLOTHO PROTEINS AND COMPOSITIONS AND METHODS INCLUDING THEM |
-
2020
- 2020-12-04 CA CA3160033A patent/CA3160033A1/en active Pending
- 2020-12-04 US US17/781,542 patent/US20230024183A1/en active Pending
- 2020-12-04 WO PCT/US2020/063319 patent/WO2021113642A1/en not_active Ceased
- 2020-12-04 KR KR1020227022987A patent/KR20220119056A/ko active Pending
- 2020-12-04 CN CN202080095849.5A patent/CN115515645A/zh active Pending
- 2020-12-04 AU AU2020398637A patent/AU2020398637A1/en active Pending
- 2020-12-04 EP EP20895465.1A patent/EP4069313A4/en active Pending
- 2020-12-04 JP JP2022534352A patent/JP7701359B2/ja active Active
-
2025
- 2025-06-19 JP JP2025104155A patent/JP2025126223A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022033855A5 (https=) | ||
| JP2025078652A5 (https=) | ||
| IL299325B2 (en) | Acid-alpha glucosidase variants and uses thereof | |
| EP2037892B1 (en) | Modified factor viii and factor ix genes and vectors for gene therapy | |
| JP2019519221A5 (https=) | ||
| JP2009526067A5 (https=) | ||
| JP2021513999A5 (https=) | ||
| EP3833746B1 (en) | Mini-gde for the treatment of glycogen storage disease iii | |
| JP7654562B2 (ja) | 線維芽細胞増殖因子２３関連低リン血症性疾患の遺伝子療法 | |
| WO2003059396A1 (en) | Adiponectin gene therapy | |
| JPWO2019152609A5 (https=) | ||
| JP2021520811A5 (https=) | ||
| JP2023065516A5 (https=) | ||
| JPWO2019165050A5 (https=) | ||
| JP2021534766A5 (https=) | ||
| JPWO2020159970A5 (https=) | ||
| US20230313152A1 (en) | C-terminal truncated gde for the treatment of glycogen storage disease iii | |
| JPWO2020186207A5 (https=) | ||
| JPWO2021113642A5 (https=) | ||
| JP2025515356A5 (https=) | ||
| JPWO2021076911A5 (https=) | ||
| JPWO2019200286A5 (https=) | ||
| RU2022111695A (ru) | Выделенная нуклеиновая кислота, которая кодирует слитый белок на основе FVIII-BDD и гетерологичного сигнального пептида, и ее применение | |
| RU2023109483A (ru) | Невирусные днк-векторы и варианты их применения для экспрессии терапевтического средства на основе фактора viii (fviii) | |
| JPWO2021195218A5 (https=) |